Termination of anti-epileptic treatments
Loiseau, P.; Henry, P.; Prissard, A.
Bordeaux Medical 5(19): 2631-2642
1972
ISSN/ISBN: 0021-7867 PMID: 4659796 Document Number: 53766
Document emailed within 1 workday
Related Documents
Kircik, L.H.; Dahl, A.; Yatskayer, M.; Raab, S.; Oresajo, C. 2012: Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 11(6): 737-740Pantazis, P.; Han, Z.; Balan, K.; Wang, Y.; Wyche, J.H. 2003: Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models Anticancer Research 23(5a): 3623-3638
Choonara, I. 2018: Anti-Epileptic Drug Toxicity in Children Children 5(5)
Foletti, G.B. 2000: Clinical utilization of new anti-epileptic agents Revue Medicale de la Suisse Romande 120(9): 703-707
Campistol, J. 2002: Teratogenic effects of epilepsy and anti epileptic drugs Revista de Neurologia 35(Suppl 1): S135-S143
Szkilnik, R.; Brus, R. 1988: Phenytoin: a new look at its anti-epileptic mechanism and adverse effects Neurologia i Neurochirurgia Polska 22(3): 246-251
Vincze, Z. 1983: Drug utilization studies among anti-epileptic agents Acta Pharmaceutica Hungarica 53(4): 159-166
O'Donoghue, M.F.; Sander, J.W. 1997: How rational is current anti-epileptic drug treatment? Revue Neurologique (Paris) 153(Suppl): S25-S28
Chapman, A.; Meldrum, B. 1991: Excitatory amino acids in epilepsy and novel anti-epileptic drugs Epilepsy Research. Suppl 3: 39-48
Bärtschi, E.; Woringer, V.; Chandesais, P. 1978: Blood monitoring for anti-epileptic drugs during treatment of epilepsy Revue Medicale de la Suisse Romande 98(4): 181-197
Borgheresi, S.; Zammarchi, E.; Buti, D.; Luti, E.; Bardini, M.R. 1977: Usefulness of the determination of blood levels of anti-epileptic drugs in pediatrics La Pediatria 85(2): 22-36
Boudin, G.; Guillard, A.; Pépin, B.; Fabiani, J.M. 1972: Our experience with a new anti-epileptic drug. Clonazepan, Ro 05 4023. Apropos of 71 cases Annales de Medecine Interne 123(6): 617-621
Salas-Puig, J. 2000: Rational anti-epileptic polytherapy. Drug interactions and choice of treatment Revista de Neurologia 30(9): 886-889
Bentolila, S.; Radenne, S.; Horellou, M.H.; Conard, J.; Samama, M.M. 1995: Hemorrhagic complications of anti-vitamin K treatments Journal des Maladies Vasculaires 20(2): 95-101
Saletu, B.; Grünberger, J. 1984: Early clinical pharmacological trials with a new anti-epileptic, milacemide, using pharmaco-EEG and psychometry Methods and Findings in Experimental and Clinical Pharmacology 6(6): 317-330
Dzudza, D.; Dzudza, M. 1979: Following of cerebrospinal fluid proteins as a method of determining and interrupting anti-epileptic therapy Medicinski Arhiv 33(1): 117-120
Roy, M.; Castro-Lionard, K.; Crawford-Achour, E.; Desseigne, N.; Beyens, M-Noelle.; Guy, C.; Imler, D.; Cornillon, D. 2011: Do medicines with aim to anti-Alzheimer favor the arisen of epileptic crisis? Discussion about 3 clinical cases Therapie 66(3): 291-293
Kumps, A. 1982: Therapeutic surveillance of anti-epileptic drugs. Determination of dosage regimen and monitoring of treatment Acta Neurologica Belgica 82(4): 209-214
Szczechowski, L.; Marczewska, E. 1987: Role of membrane receptors in the pathogenesis of epilepsy and in the mechanism of action of anti-epileptic drugs Polski Tygodnik Lekarski 42(16): 485-488
Jagiełło-Wójtowicz, E.; Kleinrok, Z.; Feldo, M.; Chodkowska, A.; Nowicky, J.W. 1992: Effect of Ukrain on the efficacy of anti-epileptic drugs against maximal electroshock-induced seizures in mice Drugs under Experimental and Clinical Research 18(Suppl): 107-109